Epstein–Barr Virus with Transforming and Early Antigen-inducing Ability Originating from Nasopharyngeal Carcinoma: Mapping of the Viral Genome

References

1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Séguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein–Barr virus genome. Nature, London 310:207–211
   [Google Scholar]
2. Bornkamm G. W., Delius H., Zimber U., Hudewentz J., Epstein M. A. 1980; Comparison of Epstein–Barr virus strains of different origin by analysis of the viral DNAs. Journal of Virology 35:603–618
   [Google Scholar]
3. Countryman J., Miller G. 1985; Activation of expression of latent Epstein–Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of SciencesU.S.A 824085–4089
   [Google Scholar]
4. Countryman J., Jenson H., Seibl R., Wolf H., Miller G. 1987; Polymorphic proteins encoded within BZLF1 of defective and standard Epstein–Barr viruses disrupt latency. Journal of Virology 61:3672–3679
   [Google Scholar]
5. Dambaugh T., Beisel C, Hummel M., King W., Fennewald S., Cheung A., Heller M., Raab-Traube N., Kieff E. 1980; Epstein–Barr virus (B95-8) DNA. VII. Molecular cloning and detailed mapping of EBV (B95-8) DNA. Proceedings of the National Academy of SciencesU.S.A 772299–3003
   [Google Scholar]
6. Dolyniuk M., Pritchett R., Kieff E. 1976; Proteins of Epstein–Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein–Barr virus. Journal of Virology 17:935–949
   [Google Scholar]
7. Heller M., Dambaugh T., Kieff E. 1981; Epstein–Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells. Journal of Virology 38:632–648
   [Google Scholar]
8. Heston L., Rabson M., Brown N., Miller G. 1982; New Epstein–Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature, London 295:160–163
   [Google Scholar]
9. Ish-Horowicz D., Burke I. F. 1981; Rapid and efficient cosmid cloning. Nucleic Acids Research 9:2989–2998
   [Google Scholar]
10. Jones M. D., Foster L., Sheedy T., Griffin B. 1984; The EBV virus genome in Daudi Burkitt’s lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of that virus. EMBO Journal 3:813–821
    [Google Scholar]
11. King W., Dambaugh T., Heller M., Dowling J., Kieff E. 1982; Epstein–Barr virus DNA. XII. A variable region of the EBV genome is included in the P3HR-1 deletion. Journal of Virology 43:979–986
    [Google Scholar]
12. Lin J. C., Raab-Traub N. 1987; Two strains of Epstein–Barr virus (B95-8 and P3HR-1 subclone) that lack defective genome induce early antigen and cause abortive infection of Raji cells. Journal of Virology 61:1985–1991
    [Google Scholar]
13. Miller G., Lipman M. 1973; Release of infectious Epstein–Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of SciencesU.S.A 70190–194
    [Google Scholar]
14. Miller G., Heston L., Countryman J. 1985; P3HR-1 Epstein–Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread. Journal of Virology 54:45–52
    [Google Scholar]
15. Raab-Traub N., Dambaugh T., Kieff E. 1980; DNA of Epstein–Barr virus. VIII. B95-8, the previous prototype is an unusual deletion derivative. Cell 22:257–267
    [Google Scholar]
16. Raab-Traub N., Flynn K., Pearson G., Huang A., Lanier A., Pagano J. S. 1987; The differentiated form of nasopharyngeal carcinoma contains Epstein–Barr virus DNA. International Journal of Cancer 39:25–29
    [Google Scholar]
17. Rabson M., Gradoville L., Heston L., Miller G. 1982; Non-immortalizing P3JHR-1 Epstein–Barr virus: a deletion mutant of its transforming parent, Jijoye. Journal of Virology 44:834–844
    [Google Scholar]
18. Rabson M., Heston L., Miller G. 1983; Identification of a rare Epstein–Barr virus variant that enhances early antigen expression in Raji cells. Proceedings of the National Academy of SciencesU.S.A 802762–2766
    [Google Scholar]
19. Sato H., Takimoto T., Ogura H., Tanaka J., Hatano M., Glaser R. 1986; Heterogeneity of Epstein–Barr virus derived from a nasopharyngeal carcinoma which has transforming and lytic properties. Journal of the National Cancer Institute 76:1019–1024
    [Google Scholar]
20. Sato H., Takimoto T., Pagano J. S., Raab-Traub N. 1988; Amplification of Epstein–Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma. Journal of Virology 62:3288–3294
    [Google Scholar]
21. Sixbey I. W., Vesterinen E. H., Nedrud I. G., Raab-Traub N., Walton L. A., Pagano I. S. 1983; Replication of Epstein–Barr virus in human epithelial cells infected in vitro. Nature, London 306:480–483
    [Google Scholar]
22. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
23. Takimoto T., Kamide M., Umeda R. 1984; Establishment of Epstein–Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT). Archives of Otorhinolaryngology 239:87–92
    [Google Scholar]
24. Takimoto T., Ogura H., Sato H., Umeda R., Hatano M. 1985; Isolation of transforming and early antigen-inducing Epstein–Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). Journal of the National Cancer Institute 74:57–59
    [Google Scholar]